Sangamo to reclaim hemophilia A therapy rights post Pfizer termination-February 2024-www.financetom.com

Sangamo to reclaim hemophilia A therapy rights post Pfizer termination

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sangamo to reclaim hemophilia A therapy rights post Pfizer termination

Dec 30, 2024 1:33 PM

Dec 30 (Reuters) - Sangamo Therapeutics ( SGMO ) said on

Monday it would regain full rights to its hemophilia A gene

therapy after co-development partner Pfizer ( PFE ) terminated

the agreement.

Previous page： Howmet Aerospace Q2 Adjusted Earnings, Sales Increase; 2024 Guidance Raised Next page： Canada's TC Energy to sell pipeline stake to some indigenous communities for $722 mln

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Howmet Aerospace Q2 Adjusted Earnings, Sales Increase; 2024 Guidance Raised

Jul 30, 2024

08:04 AM EDT, 07/30/2024 (MT Newswires) -- Howmet Aerospace ( HWM ) reported Q2 adjusted earnings Tuesday of $0.67 per diluted share, up from $0.44 a year earlier. Analysts polled by Capital IQ expected $0.60. Sales for the quarter ended June 30 were $1.88 billion, up from $1.65 billion a year earlier. Analysts polled by Capital IQ expected $1.83 billion....

Canada's TC Energy to sell pipeline stake to some indigenous communities for $722 mln

Jul 30, 2024

July 30 (Reuters) - TC Energy ( TRP ) said on Tuesday that it will sell a minority stake in its Nova Gas transmission system and the Foothills pipeline assets for C$1 billion ($722.1 million) to certain indigenous Canadian communities as part of a plan to reduce its debt and fund investments. The company, best known for its Keystone oil...

Zebra Technologies Fiscal Q2 Non-GAAP Earnings Fall, Net Sales Rise; Fiscal Q3 Guidance Set, 2024 Outlook Lifted

Jul 30, 2024

07:18 AM EDT, 07/30/2024 (MT Newswires) -- Zebra Technologies ( ZBRA ) reported fiscal Q2 non-GAAP earnings Tuesday of $3.18 per diluted share, down from $3.29 a year earlier. Analysts polled by Capital IQ expected $2.81. Net sales for the quarter ended June 29 were $1.22 billion, up from $1.21 billion a year earlier. Analysts surveyed by Capital IQ expected...

BRIEF-Vitalhub To Acquire Medcurrent Corporation

Jul 30, 2024

July 30 (Reuters) - Vitalhub Corp ( VHIBF ): * VITALHUB CORP. ( VHIBF ) TO ACQUIRE MEDCURRENT CORPORATION * VITALHUB CORP ( VHIBF ) - TO ACQUIRE MEDCURRENT FOR APPROXIMATELY C$34 MILLION Source text for Eikon: Further company coverage: ...